Clinical Trials on Urinary Tract Disease
Total 388044 results
-
Pfizer's Upjohn has merged with Mylan to form Viatris...CompletedOveractive BladderSwitzerland
-
Loyola UniversityAstellas Pharma US, Inc.Completed
-
Joint-Stock Company North-West Center for Evidence-Based...UnknownOveractive BladderRussian Federation
-
TriHealth Inc.CompletedOveractive BladderUnited States
-
Massachusetts General HospitalAstellas Pharma IncCompletedOveractive BladderUnited States
-
University of North Carolina, Chapel HillSociety of Urodynamics, Female Pelvic Medicine and Urogenital ReconstructionCompleted
-
Walter Reed National Military Medical CenterUnknownOveractive BladderUnited States
-
Mutah UniversityCompletedOveractive BladderJordan
-
Christopher J Chermansky, MDTerminated
-
Unity Health TorontoCompletedOveractive BladderCanada
-
Prof. Dr. med. Marc PossoverUnknownBladder, OveractiveSwitzerland
-
Lawson Health Research InstituteCompleted
-
Stéphane BolducPfizerCompleted
-
Assiut UniversityUnknown
-
MedtronicNeuroCompletedOveractive BladderUnited States
-
PfizerCompleted
-
University of Alabama at BirminghamPfizerCompleted
-
Weill Medical College of Cornell UniversityNaturex-DbsCompletedOveractive BladderUnited States
-
Weill Medical College of Cornell UniversityLaborie Medical Technologies Inc.; Urodynamix TechnologiesCompleted
-
Lanzhou Institute of Biological Products Co., LtdUnknown
-
University of Alabama at BirminghamCompletedOveractive Bladder | Lower Urinary Tract SymptomsUnited States
-
Buddhist Tzu Chi General HospitalCompleted
-
SK Chemicals Co., Ltd.CompletedOveractive BladderKorea, Republic of
-
Kenneth Peters, MDCompletedOveractive BladderUnited States
-
Astellas Pharma IncCompleted
-
Hanmi Pharmaceutical Company LimitedCompleted
-
Laborie Medical Technologies Inc.TerminatedOveractive Bladder | Lower Urinary Tract SymptomsUnited States, Canada, United Kingdom
-
Cantonal Hospital, FrauenfeldAstellas Pharma IncCompleted
-
UroGen Pharma Ltd.TerminatedOveractive BladderIsrael
-
AllerganCompletedOveractive BladderUnited States
-
KYU-SUNG LEEAstellas Pharma Korea, Inc.CompletedOveractive BladderKorea, Republic of
-
AllerganCompletedOveractive BladderUnited Kingdom, Belgium, New Zealand, France, Russian Federation, Czech Republic, United States, Germany, Austria, Poland, Slovakia, Ukraine, Canada, Australia
-
Astellas Pharma IncCompleted
-
University of AarhusCompleted
-
Miami VA Healthcare SystemPfizerCompletedOveractive BladderUnited States
-
AllerganTerminatedOveractive BladderUnited States, Canada, India, Australia
-
National Taiwan University HospitalTerminated
-
LG Life SciencesKyorin Pharmaceutical Co.,LtdCompletedOveractive BladderKorea, Republic of
-
University of ZurichCompleted
-
Astellas Pharma IncAstellas Pharma China, Inc.CompletedOveractive BladderChina
-
EMKinetics, IncCompletedOveractive BladderUnited States
-
University of California, IrvineCompletedOveractive BladderUnited States
-
PfizerCompletedOveractive BladderCzech Republic, Slovakia, United Kingdom, Sweden, Norway, Lithuania
-
Università degli Studi dell'InsubriaCompletedDetrusor OveractivityItaly
-
Samsung Medical CenterCompletedOveractive BladderKorea, Republic of
-
GlaxoSmithKlineCompletedOveractive BladderUnited States
-
Università degli Studi dell'InsubriaCompletedOveractive BladderItaly
-
William Beaumont HospitalsCompleted
-
University of VirginiaNational Cancer Institute (NCI)CompletedOvarian Cancer | Primary Peritoneal Cavity CancerUnited States